A559V

Category 3/4 — Most DruggableUncertain significanceCytoplasmic · predictedSource card

Alanine → Valine at position 559 · Lumenal loop 4 · WFS1 (Wolframin)

Interactive 3D Structure

Wild-type reference

Wild-type A559 — hydrogen bond to Y563

Fullscreen ↗

DynaMut2 mutant · A559V

Mutant V559 — hydrogen bond to G562 lost (5 contacts lost)

Fullscreen ↗

Bond changes · DynaMut2 interaction analysis

5 lost5 gained13 preserved

Interaction type	Wild-type partner	Mutant partner	Status
Hydrogen bond	—	S430	Gained
Hydrogen bond	—	E431	Gained
Hydrogen bond	G555	G555	Preserved
Hydrogen bond	L556	—	Lost
Hydrogen bond	G562	—	Lost
Hydrogen bond	Y563	Y563	Preserved
Polar contact	S430	S430	Preserved
Polar contact	E431	E431	Preserved
Polar contact	G555	G555	Preserved
Polar contact	L556	L556	Preserved
Polar contact	L557	L557	Preserved
Polar contact	I561	—	Lost
Polar contact	G562	G562	Preserved
Polar contact	Y563	Y563	Preserved
Carbonyl	G562	—	Lost
Van der Waals	E431	E431	Preserved
Van der Waals	—	G555	Gained
Van der Waals	—	L557	Gained
Van der Waals	G562	—	Lost
Hydrophobic	E431	E431	Preserved
Hydrophobic	V434	V434	Preserved
Hydrophobic	—	L556	Gained
Hydrophobic	Y563	Y563	Preserved

Lost / gained / preserved interatomic contacts at the variant residue, from the DynaMut2 (Arpeggio) interaction analysis of the wild-type and energy-minimized mutant structures.

Computational Predictions

DynaMut2 ΔΔG

-1.16kcal/mol

Destabilising — moderate

AlphaMissense

0.778

likely pathogenic

AlphaFold pLDDT

model confidence

Schema

Cat 3/4

Category 3/4 — Most Druggable

Clinical Evidence

ClinVar classificationUncertain significance/Uncertain risk allele

Review statuscriteria provided, multiple submitters, no conflicts

Associated conditionsWolfram syndrome 1

Population frequency (gnomAD v4)Ultra-rare · AF 0.00037%

cDNA changec.1676C>T

ClinVar accessionVCV001521787

Last evaluated2023/10/09 00:00

Observed at very low frequency in gnomAD.

Full Variant Card

WFS1 Wolframin — A559V Variant Card

Molecular Atlas Pilot · RareResearch.AI · Generated by wolfram-variant-card skill

Alanine → Valine at position 559. Lumenal loop 4. ClinVar Uncertain significance/Uncertain risk allele, AlphaMissense 0.778, DynaMut2 ΔΔG -1.16 kcal/mol (destabilising).

Identity

Field	Value
Variant	A559V (p.Alanine559Valine)
DNA change	c.1676C>T
Gene · Protein	WFS1 · Wolframin (890 aa)
UniProt	O76024 · WFS1_HUMAN
ClinVar accession	VCV001521787
Amino acid change	Alanine (A) → Valine (V)

Structural Context

Field	Value
AlphaFold model	AF-O76024-F1, v6
pLDDT at residue 559	87.12 — well-folded
Domain	Lumenal loop 4
Position context	C-terminal lumenal domain · position 559 projects into the ER lumen
IDR flag	No — pLDDT above 50 threshold

UniProt features at this position:

(none catalogued)

Position 559 sits in the C-terminal lumenal domain (residues 653–869), wolframin's largest soluble region. This domain projects into the ER lumen and is implicated in calcium handling, ER stress sensing, and protein–protein interactions with ATF6 and Na+/K+ ATPase β1. The wild-type residue is small/hydrophobic (alanine — methyl sidechain); the mutant is small hydrophobic (valine — branched). The chemistry shift implies altered local packing, hydrogen-bonding, and/or electrostatics at this site.

Computational Predictions

AlphaMissense

Field	Value
am_pathogenicity	0.7783
am_class	likely pathogenic
Interpretation	Likely pathogenic (threshold 0.564)

DynaMut2

Field	Value
ΔΔG (kcal/mol)	-1.16 (Destabilising)
Job ID	178092118237
Result URL	https://biosig.lab.uq.edu.au/dynamut2/results_prediction/178092118237

Clinical Evidence

Field	Value
Classification	Uncertain significance/Uncertain risk allele
Review status	criteria provided, multiple submitters, no conflicts
Last evaluated	2023/10/09 00:00
Inheritance	Autosomal recessive Wolfram syndrome 1 phenotype documented.
WFS1 variant landscape	A559V is 1 of ~326 pathogenic-spectrum variants in WFS1 (out of 2,243 catalogued in ClinVar)

Wolfram syndrome 1

Research Path Decision Tree

ΔΔG < 2  + binding site affected   →  CATEGORY 3 — docking experiments
ΔΔG 2–4                            →  CATEGORY 2 — pharmacological chaperones
ΔΔG > 4                            →  CATEGORY 1 — gene therapy
pLDDT < 50                         →  CATEGORY 5 — IDR, experimental only
Stable fold + functional site hit  →  CATEGORY 4 — site-specific docking

Final Schema Categorization

Category 3/4 — Most Druggable

<strong>Category 3/4 — Most Druggable</strong><br/><br/>|ΔΔG|=1.16 < 2 kcal/mol (fold intact) + AlphaMissense 0.778 confirms functional impact. Specific local contacts disrupted — priority for docking and pharmacological chaperone screening.

Why this card matters. Wolframin's fold survives this substitution (|ΔΔG|=1.16 kcal/mol). The pathogenic signal is real — AlphaMissense places it at 0.778. Protein still folds, but a specific local site is broken. Pharmacological chaperones and small-molecule binders are the rational therapeutic vector.

Files in this folder

AF-O76024-F1-model_v6.pdb — AlphaFold structure
A559V_molstar_viewer.html — interactive 3D viewer (auto-highlights position 559 with ball-and-stick + neighbors within 5Å)
A559V_variant_card.md — this card (source of truth)
A559V_variant_card.html — styled printable card
A559V_dynamut2_summary.html — clean offline DynaMut2 result card
dynamut2_result.json — structured result data
dynamut2_result_page.html — local snapshot of the Biosig result page (asset URLs absolutized)
A559V_wildtype_interactions.pse / A559V_mutant_interactions.pse — PyMOL sessions

Generated by wolfram-variant-card skill · RareResearch.AI Molecular Atlas Every assumption documented. Every score sourced.

Therapeutic Strategy Handoff · prediction

Feed this card to Wolfram Intelligence

Download the A559V PDF below and upload it to Wolfram Intelligence to generate therapeutic-strategy proposals — guanidinium mimetics, sigma-1 agonist docking, NAC thiol-capping. NAC is already on the bench-testing list.

Download A559V PDF card ↓Strategies are AI-generated predictions, not validated therapeutics.